| Execution period | 60 months |
|---|
NSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,279.50
- Market cap
- ₹15,699 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 92.5×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India Ltd declared the voting results of its postal ballot, confirming the appointment and designation change of certain non-executive directors.
AstraZeneca Pharma India Other Announcement
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
- Value
- ₹0.03 Cr
- From
- Registrar of Companies, Bengaluru, Karnataka
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma disclosed a ₹1.88 lakh penalty from the Registrar of Companies due to a delay in filing Form MR-2.
- Value
- ₹0.02 Cr
AstraZeneca Pharma India Management Change
AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.
Other management change announcements
All →Tokyo Plast International Management Change
Tokyo Plast International appointed Ms. Ayushi Deepak Doshi as Company Secretary and Compliance Officer, a KMP, effective 29 October 2026. The intimation lists her credentials and states no director relationships.
Globus Power Generation Management Change
Globus Power Generation appointed Devesh Bhargava as Independent Director for five years, subject to shareholder approval. Thamattoor Prabhakaran Nair resigned as Independent Director effective 30 October 2026.
- Execution
- 5 years (29 Oct 2026 to 28 Oct 2031)
Meesho Management Change
Meesho appointed Sudhir Ganesh Sitapati as Additional Non-Executive Independent Director for 60 months, effective 28 October 2026. He is a former Godrej Consumer Products MD and CEO.
Aplab Management Change
APLAB Limited appointed Rakesh Margam as Company Secretary and Compliance Officer, effective 29 October 2026. The change is a senior management appointment with no financial impact.
Indostar Capital Finance Management Change
IndoStar Capital's Company Secretary and Compliance Officer Shikha Jain resigned effective 29 October 2026. Reshma Ramchandani was appointed in her place from 30 October 2026.
Greenply Industries Management Change
Greenply Industries appointed Gaurav Drolia as Executive Vice President and Chief Strategy Officer, effective October 31, 2026. He is also designated Senior Management Personnel.